Omni Star Financial Group, Inc. Gilead Sciences, Inc. Transaction History
Omni Star Financial Group, Inc.
- $115 Million
- Q1 2025
A detailed history of Omni Star Financial Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Omni Star Financial Group, Inc. holds 12,259 shares of GILD stock, worth $1.39 Million. This represents 1.19% of its overall portfolio holdings.
Number of Shares
12,259
Previous 17,784
31.07%
Holding current value
$1.39 Million
Previous $1.64 Million
16.38%
% of portfolio
1.19%
Previous 1.4%
Shares
29 transactions
Others Institutions Holding GILD
# of Institutions
2,287Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13.3 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.73 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.17 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.05 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $142B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...